Real‐time continuous glucose monitoring immediately after severe hypoglycaemia requiring emergency medical services: A randomised controlled trial
Authors' conclusion
RTCGM implemented acutely after an episode of severe hypoglycaemia is feasible and clinically effective with important implications for hypoglycaemia management pathways and self-monitoring cost effectiveness.
Study context
- Population
- Adults with T1D in the acute period after an episode of severe hypoglycaemia requiring emergency medical services30 completed
- Participants
- 35 adults
- Comparison
- Real-time continuous glucose monitoring (RTCGM) with alerts and alarms vs usual care with SMBG
- Primary endpoint
- Difference between groups in percentage time spent in hypoglycaemia (≤3.0 mmol/L, 55 mg/dL)
- Follow-up
- 12 weeks
Primary result
As reported in the abstract
Change in exposure to glucose below 3.0 mmol/L
RTCGM
−0.16
range or interval (as printed) −1.23–0.01
SMBG
1.58
range or interval (as printed) 0.41–3.48
P = 0.03
Further findings
| Outcome | RTCGM | SMBG | P value |
|---|---|---|---|
| Episodes of nocturnal hypoglycaemiaSignificantly larger reduction with RTCGM | −0.03 (range or interval (as printed) −0.15–0.02) | 0.05 (range or interval (as printed) −0.03–0.40) | P = 0.02 |
Safety
| Outcome | RTCGM | SMBG | P value |
|---|---|---|---|
| Episodes of severe hypoglycaemiaSignificantly lower with RTCGM | 0.0 | 4.0 | p 0.04 |
Original publication
Real‐time continuous glucose monitoring immediately after severe hypoglycaemia requiring emergency medical services: A randomised controlled trial. Diabet Med. Published 18 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →